These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7323129)

  • 1. Pharmacological properties of N-aminodiphenylhydantoin, a new hydantoin derivative with anticonvulsant activity.
    Rump S; Ilczuk I; Rabsztyn T; Walczyna K
    Pharmazie; 1981 Nov; 36(11):780-1. PubMed ID: 7323129
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparison of anticonvulsant properties of commercial diphenylhydantoin (DPH) and its 3-amino-derivative (3-amino-DPH).
    Kozicka M
    Ann Univ Mariae Curie Sklodowska Med; 1993; 48():57-60. PubMed ID: 8534164
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):23-39. PubMed ID: 4438826
    [No Abstract]   [Full Text] [Related]  

  • 5. p-Aminobenzene sulphonyl morpholine, compound 82/208 a new anticonvulsant agent.
    Dua PR; Ahuja P; Anand N
    Indian J Exp Biol; 1994 Oct; 32(10):729-31. PubMed ID: 7821984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of aryl and hetarylsulfonylhydrazones.
    Darias V; Abdallah S; Delgado L; Vega S
    Pharmazie; 1995 Nov; 50(11):756-8. PubMed ID: 8570673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship in a series of new 1-(2-pyrimidinyl)piperazine derivatives with hypnotic activity.
    Chilmonczyk Z; Bogdal M; Mazgajska M; Cybulski J; Lewandowska U
    Pol J Pharmacol; 1996; 48(4):431-40. PubMed ID: 9112684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary pharmacological investigations of N-amino-diphenyl-hydantoin, a new hydantoin derivative with prolonged action.
    Rump S; Ilczuk I; Walczyna K; Zadrozyńska E
    Monogr Neural Sci; 1980; 5():163-7. PubMed ID: 7322149
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the anticonvulsant properties of 2-diethylaminopento-4-ynoyl-2',6'-xylidide (WY 21745) with lignocaine, phenytoin, phenobarbitone and trimethadione.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):405-14. PubMed ID: 5559826
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and anticonvulsant properties of some arylsuccinate methylpyridylimides.
    Zejc A; Obniska J; Wilimowski M; Rutkowská M; Witkowska M; Barczyńska J; Kedzierska-Goździk L; Wojewódzki W; Orzechowska-Juzwenko K; Pławiak T
    Pol J Pharmacol Pharm; 1990; 42(1):69-77. PubMed ID: 2281022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.
    Lange J; Lapszewicz J
    Acta Pol Pharm; 1990; 47(1-2):31-4. PubMed ID: 12959256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological properties of decahydro-5H-pyrido [1',2';5,1] imidazo [3,4-a]-beta-carbolines. Part II.
    Misztal S; Dukat M; Chojnacka-Wójcik E; Tatarczyńska E
    Pol J Pharmacol Pharm; 1988; 40(4):429-33. PubMed ID: 3222182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of some xanthone derivatives.
    Rajtar G; Zółkowska D; Kleinrok Z; Marona H
    Acta Pol Pharm; 1999; 56(4):311-8. PubMed ID: 10635365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of new monoterpene homologues of GABA on the central nervous system activity in mice.
    Librowski T; Czarnecki R; Mendyk A; Jastrzebska M
    Pol J Pharmacol; 2000; 52(4):317-21. PubMed ID: 11345489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse.
    Raines A; Niner JM; Pace DG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):315-22. PubMed ID: 4719784
    [No Abstract]   [Full Text] [Related]  

  • 17. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile.
    Masuda Y; Karasawa T; Shiraishi Y; Hori M; Yoshida K; Shimizu M
    Arzneimittelforschung; 1980; 30(3):477-83. PubMed ID: 7387759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic interactions of albutoin with other anticonvulsant drugs.
    Wallin RF; Blackburn WH; Napoli MD
    J Pharmacol Exp Ther; 1970 Aug; 174(2):276-82. PubMed ID: 5451364
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):79-89. PubMed ID: 507999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(11):2125-8. PubMed ID: 580013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.